Impairments in DNA repair enzymes have been observed in amyotrophic lateral sclerosis (ALS) tissues, particularly in the activity of the apurinic/apyrimidinic endonuclease 1 (APEX1). Moreover, it was suggested that the common APEX1 Asp148Glu polymorphism might be associated with ALS risk. To further address this question we performed the present study aimed at evaluating the contribution of the APEX1 Asp148Glu polymorphism in sporadic ALS (sALS) risk and clinical presentation, including age and site of onset and disease progression. We screened 134 sALS Italian patients and 129 matched controls for the presence of the APEX1 Asp148Glu polymorphism. No difference in APEX1 Asp148Glu allele and genotype frequencies was found between the groups, nor was the polymorphism associated with age and site of onset or disease progression. Present results do not support a role for the APEX1 Asp148Glu polymorphism in sALS pathogenesis in the Italian population.
|Autori:||COPPEDÈ F; LO GERFO A; CARLESI C; PIAZZA S; MANCUSO M; PASQUALI L; MURRI L; MIGLIORE L; SICILIANO G|
|Titolo:||Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis|
|Anno del prodotto:||2008|
|Digital Object Identifier (DOI):||10.1016/j.neurobiolaging.2008.03.018|
|Appare nelle tipologie:||1.1 Articolo in rivista|